Tivozanib, sold under the brand name Fotivda, is a medication used for the treatment of relapsed or refractory advanced renal cell carcinoma. It is an oral VEGF receptor tyrosine kinase inhibitor. Reference standards of Tivozanib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Tivozanib
Catalogue No.:PA 73 42000
CAS :
Molecular Formula : C22H19ClN4O5
Molecular Weight : 454.86
Tivozanib 13CD3
Catalogue No.:PA STI 089533
Molecular Formula : C2113CH16D3ClN4O5
Molecular Weight : 458.88
Tivozanib D6
Catalogue No.:PA STI 089672
Molecular Formula : C22H13D6ClN4O5
Molecular Weight : 460.9
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....